| [1] |
|
| [2] |
ZengH, ChenW, ZhengR, et al. Changing cancer survival in China during 2003‑15: a pooled analysis of 17 popula-tion‑based cancer registries[J]. Lancet Glob Health,2018,6(5):e555‑e567. DOI: 10.1016/S2214-109X(18)30127-X.
|
| [3] |
BuellJF, CherquiD, GellerDA, et al. The international position on laparoscopic liver surgery: The Louisville Statement,2008[J]. Ann Surg,2009,250(5):825‑830. DOI: 10.1097/sla.0b013e3181b3b2d8.
|
| [4] |
WakabayashiG, CherquiD, GellerDA, et al. Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka[J]. Ann Surg,2015,261(4):619‑629. DOI:10.1097/SLA.000 0000000001184.
|
| [5] |
Abu HilalM, AldrighettiL, DagherI, et al. The southampton consensus guidelines for laparoscopic liver surgery: from indication to implementation[J]. Ann Surg,2018,268(1):11‑18. DOI: 10.1097/SLA.0000000000002524.
|
| [6] |
TwaijA, PucherPH, SodergrenMH, et al. Laparoscopic vs open approach to resection of hepatocellular carcinoma in patients with known cirrhosis: systematic review and meta‑analysis[J]. World J Gastroenterol,2014,20(25):8274-8281. DOI: 10.3748/wjg.v20.i25.8274.
|
| [7] |
TroisiRI, BerardiG, MoriseZ, et al. Laparoscopic and open liver resection for hepatocellular carcinoma with Child‑Pugh B cirrhosis: multicentre propensity score‑matched study[J]. Br J Surg,2021,108(2):196‑204. DOI:10.1093/bjs/zna a041.
|
| [8] |
ChiowA, FuksD, ChoiGH, et al. International multicentre propensity score‑matched analysis comparing robotic versus laparoscopic right posterior sectionectomy[J]. Br J Surg,2021,108(12):1513‑1520. DOI: 10.1093/bjs/znab321.
|
| [9] |
ChongCC, FuksD, LeeKF, et al. Propensity score‑matched analysis comparing robotic and laparoscopic right and exten-ded right hepatectomy[J]. JAMA Surg,2022,157(5):436-444. DOI: 10.1001/jamasurg.2022.0161.
|
| [10] |
D′SilvaM, HanHS, LiuR, et al. Limited liver resections in the posterosuperior segments: international multicentre propensity score‑matched and coarsened exact‑matched analysis comparing the laparoscopic and robotic approa-ches[J]. Br J Surg,2022,109(11):1140‑1149. DOI: 10.1093/bjs/znac270.
|
| [11] |
SucandyI, RaymanS, LaiEC, et al. Robotic versus laparos-copic left and extended left hepatectomy: an international multicenter study propensity score‑matched analysis[J]. Ann Surg Oncol,2022,29(13):8398‑8406. DOI: 10.1245/s10434-022-12216-6.
|
| [12] |
YangHY, ChoiGH, ChinKM, et al. Robotic and laparosco-pic right anterior sectionectomy and central hepatectomy: multicentre propensity score‑matched analysis[J]. Br J Surg,2022,109(4):311‑314. DOI: 10.1093/bjs/znab463.
|
| [13] |
|
| [14] |
HuY, GuoK, XuJ, et al. Robotic versus laparoscopic hepatectomy for malignancy: a systematic review and meta-analysis[J]. Asian J Surg,2021,44(4):615‑628. DOI:10.10 16/j.asjsur.2020.12.016.
|
| [15] |
CaiW, WangJ, YinD, et al. Retroperitoneal laparoscopic hepatectomy for a subcapsular hepatocellular carcinoma in segment Ⅵ (Video)[J]. Ann Surg Oncol,2023,30(9):5450-5451. DOI: 10.1245/s10434-023-13645-7.
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
MarreroJA, KulikLM, SirlinCB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases[J]. Hepatology,2018,68(2):723‑750. DOI: 10.1002/hep.29913.
|
| [20] |
European Association for the Study of the Liver. EASL clini-cal practice guidelines: management of hepatocellular carci-noma[J]. J Hepatol,2018,69(1):182‑236. DOI: 10.1016/j.jhep.2018.03.019.
|
| [21] |
OmataM, ChengAL, KokudoN, et al. Asia‑Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update[J]. Hepatol Int,2017,11(4):317-370. DOI: 10.1007/s12072-017-9799-9.
|
| [22] |
LiaoM, ZhongX, ZhangJ, et al. Radiofrequency ablation using a 10‑mm target margin for small hepatocellular carcinoma in patients with liver cirrhosis: A prospective randomized trial[J]. J Surg Oncol,2017,115(8):971‑979. DOI: 10.1002/jso.24607.
|
| [23] |
TakayamaT, HasegawaK, IzumiN, et al. Surgery versus radiofrequency ablation for small hepatocellular carcinoma: a randomized controlled trial (SURF trial)[J]. Liver Cancer,2022,11(3):209‑218. DOI: 10.1159/000521665.
|
| [24] |
KudoM, HasegawaK, KawaguchiY, et al. A multicenter ran-domized controlled trial to evaluate the efficacy of surgery versus radiofrequency ablation for small hepatocellular carcinoma (SURF trial): analysis of overall survival[J]. J Clin Oncol,2021,39:4093. DOI:10.1200/JCO.2021.39. 15_SUPPL.4093.
|
| [25] |
XiaY, LiJ, LiuG, et al. Long‑term effects of repeat hepatectomy vs percutaneous radiofrequency ablation among pati-ents with recurrent hepatocellular carcinoma: a randomi-zed clinical trial[J]. JAMA Oncol,2020,6(2):255‑263. DOI: 10.1001/jamaoncol.2019.4477.
|
| [26] |
LeeDH, LeeMW, KimPN, et al. Outcome of no‑touch radio-frequency ablation for small hepatocellular carcinoma: a multicenter clinical trial[J]. Radiology,2021,301(1):229-236. DOI: 10.1148/radiol.2021210309.
|
| [27] |
YuJ, ChengZG, HanZY, et al. Period‑dependent survival benefit of percutaneous microwave ablation for hepatocellular carcinoma: a 12‑year real‑world, multicentric experi-ence[J]. Liver Cancer,2022,11(4):341‑353. DOI: 10.1159/000522134.
|
| [28] |
WangZ, LiuM, ZhangDZ, et al. Microwave ablation versus laparoscopic resection as first‑line therapy for solitary 3-5-cm HCC[J]. Hepatology,2022,76(1):66‑77. DOI: 10.1002/hep.32323.
|
| [29] |
AnC, LiWZ, HuangZM, et al. Small single perivascular hepa-tocellular carcinoma: comparisons of radiofrequency abla-tion and microwave ablation by using propensity score analysis[J]. Eur Radiol,2021,31(7):4764‑4773. DOI: 10.1007/s00330-020-07571-5.
|
| [30] |
FengY, WangL, LvH, et al. Microwave ablation versus radiofrequency ablation for perivascular hepatocellular carcinoma: a propensity score analysis[J]. HPB (Oxford),2021,23(4):512‑519. DOI: 10.1016/j.hpb.2020.08.006.
|
| [31] |
WangC, WangH, YangW, et al. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofre-quency ablation in hepatocellular carcinoma[J]. Hepatology,2015,61(5):1579‑1590. DOI: 10.1002/hep.27548.
|
| [32] |
EiS, HibiT, TanabeM, et al. Cryoablation provides superior local control of primary hepatocellular carcinomas of >2 cm compared with radiofrequency ablation and microwave coagulation therapy: an underestimated tool in the toolbox[J]. Ann Surg Oncol,2015,22(4):1294‑1300. DOI: 10.1245/s10434-014-4114-7.
|
| [33] |
LuoJ, DongZ, XieH, et al. Efficacy and safety of percutaneous cryoablation for elderly patients with small hepatocellular carcinoma: a prospective multicenter study[J]. Liver Int,2022,42(4):918‑929. DOI: 10.1111/liv.15169.
|
| [34] |
AbdoJ, CornellDL, MittalSK, et al. Immunotherapy plus cryotherapy: potential augmented abscopal effect for advan-ced cancers[J]. Front Oncol,2018,8:85. DOI:10.3389/fonc. 2018.00085.
|
| [35] |
DaiZ, WangZ, LeiK, et al. Irreversible electroporation induces CD8(+) T cell immune response against post-ablation hepatocellular carcinoma growth[J]. Cancer Lett,2021,503:1‑10. DOI: 10.1016/j.canlet.2021.01.001.
|
| [36] |
WadaT, SugimotoK, SakamakiK, et al. Comparisons of radio-frequency ablation, microwave ablation, and irreversible electroporation by using propensity score analysis for early stage hepatocellular carcinoma[J]. Cancers (Basel),2023,15(3):732. DOI: 10.3390/cancers15030732.
|
| [37] |
QiuB, AiliA, XueL, et al. Advances in radiobiology of stereotactic ablative radiotherapy[J]. Front Oncol,2020,10:1165. DOI: 10.3389/fonc.2020.01165.
|
| [38] |
BaeSH, ChunSJ, ChungJH, et al. Stereotactic body radiation therapy for hepatocellular carcinoma: meta‑analysis and international stereotactic radiosurgery society practice guidelines[J]. Int J Radiat Oncol Biol Phys,2024,118(2):337‑351. DOI: 10.1016/j.ijrobp.2023.08.015.
|
| [39] |
SuTS, LiangP, LiangJ, et al. Long‑term survival analysis of stereotactic ablative radiotherapy versus liver resection for small hepatocellular carcinoma[J]. Int J Radiat Oncol Biol Phys,2017,98(3):639‑646. DOI:10.1016/j.ijrobp.2017.02. 095.
|
| [40] |
|
| [41] |
SalemR, GordonAC, MouliS, et al. Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma[J]. Gastroenterology,2016,151(6):1155‑1163.e2. DOI: 10.1053/j.gastro.2016.08.029.
|
DownLoad: